SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemox Laboratories Ltd (BENTOLCHEM) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 524464 NSE: BENTOLCHEM | Pharmaceuticals & Drugs |

BSE Share Price
Not Listed

Chemox Laboratories Ltd (BENTOLCHEM)

BSE: 524464 NSE: BENTOLCHEM
Key Metrics
Market Cap
₹0 Cr.
P/E Ratio
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Return on Capital Employed (ROCE)
%
Current Price
₹0
Return on Equity (ROE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
NAN%
Gross Profit Margin
0%
Book Value per Share
₹0
Sales Growth (YoY)
%
Sales Growth (3 Years)
%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹0 / 0
Net Profit Growth (3 Years)
N/A%
Dividend Yield
%
Promoter Holding
%
Pledged shares (%)
of Promoter's holding (%)
%

DeciZen - make an informed investing decision on Chemox Labs

Based on:

M-Cap below 100cr DeciZen not available

Chemox Laboratories stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Information and data for this Company is currently unavailable.
We assure our users that information and data for the company will be available soon.

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) 2.00 / 23.65
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Chemox Labs - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
data
No data found!

Cash Flow

(All Figures are in Crores.)
data
No data found!

Finance Ratio

data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Chemox Laboratories Ltd FAQs

The current trading price of Chemox Labs on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Chemox Labs stood at ₹0.00 Cr

The latest P/E ratio of Chemox Labs as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Chemox Labs as of 31-Dec-1969 is 0.00.

The 52-week high of Chemox Labs is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemox Labs is ₹0.00 ( Cr.) .

About Chemox Laboratories Ltd

Chemox Laboratories (CLL), promoted by S. N. Agarwal, was incorporated as Bentoll Chemical Products Ltd (a private limited company) in Maharashtra on June 28, 1982. It was converted into a public limited company on September 29, 1992, and obtained a fresh certificate of incorporation on January 3, 1994.

It started with a 300 tpa plant to manufacture Analgin (a pharmaceutical product used in formulations of painkillers), where commercial production commenced from March 1991. The name was changed to the present one in financial year 1996.

Business of the company:

CLL is also engaged in the marketing and exports of organic, inorganic chemicals and petrochemical products. It also has a fleet of stainless steel tankers for captive transportation, which ensures lower transportation costs. Presently, it has capacities or manufacturing analgin IP, phenyl methyl pyrazolone, sodium bi-sulphate, acetyl sulphonyl chloride, acetanilide, sulphanilic acid and formulation products.

CLL became a sick company in FY99 under the Sick Industrial Companies (Special Provisions) Act, 1985, and was  registered with the Board for Industrial and Financial Reconstruction, which appointed ICICI Ltd as an operating agency for the company. CLL has submitted a revival proposal to the operating agency. In its notice to the NSE on December 13, 1999, CLL proposed a change in management from the existing promoter group of S.N.Agarwal to P. Rajarathinam, who acquired several sick companies and turned them into profitable undertakings.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×